Anne‐Sophie Ribba

An Experimental Model to Study the in Vivo Survival of von Willebrand Factor

Peter J. Lenting, Erik Westein, Virginie Terraube et al. · Journal of Biological Chemistry · 2004 · 159 citations · Full text

Pharmacy, Molecular Biology, Pharmacokinetics +11

β1 integrin–dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin

Hiba Sabra, Molly Brunner, Vinay Mandati et al. · Journal of Biological Chemistry · 2017 · 124 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw–Schulman syndrome)

Agnès Veyradier, J. M. Lavergne, Anne‐Sophie Ribba et al. · Journal of Thrombosis and Haemostasis · 2004 · 113 citations · Full text

Life Sciences, Genetics, Molecular Genetics +8

Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease.

Dominique Meyer, E Fressinaud, Céline Gaucher et al. · PubMed · 1997 · 96 citations

Life Sciences, Genetics, Molecular Genetics +12

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study

Jeroen Eikenboom, Lysiane Hilbert, Anne‐Sophie Ribba et al. · Journal of Thrombosis and Haemostasis · 2009 · 61 citations

Life Sciences, Genetics, Molecular Genetics +13